Atlas Trials

Study Evaluating Safety & Immunogenicity of rLP2086 Vaccine in Adolescents

Clinical trial NCT00387725 · COMPLETED

Trial details

NCT number
NCT00387725
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Healthy
Start date
2006-11-01
Primary completion
2008-01-01
Enrollment
127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.